2003
DOI: 10.1097/00006250-200310000-00013
|View full text |Cite
|
Sign up to set email alerts
|

Outcome of Fertility-Sparing Treatment With Progestins in Young Patients With Endometrial Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
94
1
2

Year Published

2006
2006
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(97 citation statements)
references
References 29 publications
0
94
1
2
Order By: Relevance
“…The first case reports regarding conservative treatment of endometrial cancer were published in the early 1960s. Since then, the safety and efficacy of hormonal therapy as a primary treatment of endometrial cancer in reproductive age have been reported in several articles (13,14). Lately, papers have been published about hysteroscopic resection of the endometrium in order to preserve fertility (15), and hysteroscopic endomyometrial resection as an alternative treatment to hysterectomy for an early stage endometrial cancer in both pre-and postmenopausal women (16).…”
Section: Discussionmentioning
confidence: 99%
“…The first case reports regarding conservative treatment of endometrial cancer were published in the early 1960s. Since then, the safety and efficacy of hormonal therapy as a primary treatment of endometrial cancer in reproductive age have been reported in several articles (13,14). Lately, papers have been published about hysteroscopic resection of the endometrium in order to preserve fertility (15), and hysteroscopic endomyometrial resection as an alternative treatment to hysterectomy for an early stage endometrial cancer in both pre-and postmenopausal women (16).…”
Section: Discussionmentioning
confidence: 99%
“…However, progesterone therapy has been used for young women with either atypical endometrial hyperplasia or grade 1 endometrial hyperplasia who desire fertility preservation and women who are very poor surgical candidates. 14,66,67 …”
Section: Hormone Replacement Therapy For Endometrial Cancersmentioning
confidence: 99%
“…Response to treatment has been high (rates of 73%-81%), but not absolute [28][29][30][31] . Recurrence rates are also appreciable (18%-40% with follow-up times up to 357 months) [28][29][30][32][33][34] . Although progestin management of early endometrial carcinoma has shown success (recent pregnancy rates of 40% and subsequent live birth rates up to 47% 30 ), this management route is evidently not without risk.…”
Section: Progestins and Endometrial Cancermentioning
confidence: 99%